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Background: Maspin, a putative tumor suppressor that is down-regulated in breast and prostate cancer, has been
associated with decreased cell motility. Snail transcription factor is a zinc finger protein that is increased in breast
cancer and is associated with increased tumor motility and invasion by induction of epithelial-mesenchymal
transition (EMT). We investigated the molecular mechanisms by which Snail increases tumor motility and invasion
utilizing prostate cancer cells.
Methods: Expression levels were analyzed by RT-PCR and western blot analyses. Cell motility and invasion assays
were performed, while Snail regulation and binding to maspin promoter was analyzed by luciferase reporter and
chromatin immunoprecipitation (ChIP) assays.
Results: Snail protein expression was higher in different prostate cancer cells lines as compared to normal prostate
epithelial cells, which correlated inversely with maspin expression. Snail overexpression in 22Rv1 prostate cancer
cells inhibited maspin expression and led to increased migration and invasion. Knockdown of Snail in DU145 and
C4-2 cancer cells resulted in up-regulation of maspin expression, concomitant with decreased migration.
Transfection of Snail into 22Rv1 or LNCaP cells inhibited maspin promoter activity, while stable knockdown of Snail
in C4-2 cells increased promoter activity. ChIP analysis showed that Snail is recruited to the maspin promoter in
22Rv1 cells.
Conclusions: Overall, this is the first report showing that Snail can negatively regulate maspin expression by
directly repressing maspin promoter activity, leading to increased cell migration and invasion. Therefore, therapeutic
targeting of Snail may be useful to re-induce expression of maspin tumor suppressor and prevent prostate cancer
tumor progression.
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Snail transcription factor is a zinc finger protein that
induces epithelial-mesenchymal transition (EMT) via loss
of E-cadherin expression and gain of vimentin expression,
leading to increased cell migration, invasion, and tumori-
genicity [1-4]. This transcription factor functions as a* Correspondence: vodero_marah@cau.edu
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reproduction in any medium, provided the orrepressor by having its zinc finger motifs bind to E-boxes
along the CDH1 (E-cadherin) promoter thereby repressing
transcription (Cano et al., 2000). The expression of Snail
and the phenotypical changes associated with EMT have a
profound impact of cell movement.
Snail overexpression has been shown in breast cancer
and is associated with mammary tumor recurrence [5].
Snail is overexpressed in prostate cancer as well and has
been reported to repress Raf kinase inhibitor protein
(RKIP) at the transcriptional level in metastatic prostate
cancer cell lines [6,7]. Interestingly, androgens (dihydro-
testosterone, DHT) has been shown to induce EMT ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pression levels of androgen receptor (AR) correlated in-
versely with androgen-mediated EMT suggesting that
low levels of AR was required for the EMT phenotype
[8]. Snail can also induce neuroendocrine differentiation
in LNCaP cells associated with increased paracrine cell
proliferation [9].
Maspin (mammary serine protease inhibitor) is a puta-
tive tumor suppressor that is down-regulated during
breast and prostate tumor progression [10,11]. It is a
serine protease inhibitor that has been shown to regulate
urokinase (uPA) and Rac-1 Rho GTPase activities and
thus lead to decreased invasion and migration [12-14].
Several mechanisms have been suggested for down-
regulation of maspin. Maspin suppression during cancer
progression has been shown to be mediated by promoter
methylation in several cancers including breast cancer
[15,16]. Transcription factors like mutant p53 and AR
have also been shown to bind to maspin promoter and
mediate its inhibition in prostate cancer [13,17,18]. The
maspin promoter contains a negative regulatory hor-
mone response element (HRE) that can be bound by AR
leading to inhibition of maspin promoter activity [13,18].
Although the effect of maspin has been studied in sev-
eral cancers, there is no report that correlates the ex-
pression of maspin with Snail.
Previously, we have shown that Snail promotes EMT
in ARCaP and LNCaP cells associated with increased
cell migration [9,19]. In this study, we utilized normal
and prostate cancer cell lines to show that Snail overex-
pression in cancer correlates inversely with maspin
down-regulation. We showed that Snail may inhibit
maspin protein expression by directly binding maspin
promoter, resulting in repression of maspin promoter
activity. This may explain one of the many mechanisms
by which maspin is lost during tumor progression and
opens up novel therapeutic avenues by which we could
essentially target Snail to re-express maspin resulting in
a halt to tumor progression in prostate cancer.
Methods
Reagents and antibodies
RPMI medium and penicillin/streptomycin were pur-
chased from VWR Int., West Chester, PA. The protease
inhibitor cocktail was from Roche Molecular Biochem-
icals, Indianapolis, IN. Mouse monoclonal anti-human
maspin antibody was from BD Transduction Laborator-
ies, Lexington, KY. G418 and anti-human actin anti-
bodies were from Sigma-Aldrich, Inc., St Louis, MO. Rat
monoclonal anti-human Snail antibody and HRP-
conjugated goat anti-rat antibody were from Cell Signal-
ing Technology, Inc., Danvers, MA. HRP-conjugated
sheep anti-mouse, sheep anti-rabbit and the Enhanced
chemiluminescence (ECL) detection reagent were purchasedfrom Amersham Biosciences, Buckingham, England. Fetal
bovine serum (FBS) and Charcoal/dextran treated FBS
(DCC-FBS) were from Hyclone, South Logan, UT. The
pGL3-basic vector, β-galactosidase cDNA, Sac I and Bgl II
restriction enzymes were purchased from Promega, Madi-
son, WI. The Snail cDNA construct was kindly provided by
Dr Mien-Chie Hung, University of Texas, Houston, TX.
Control and Snail siRNA constructs were from Dharma-
con, Lafayette, Co. The full length maspin promoter in
pCR2.1TOPO vector were a kind gift from Dr Zhila
Khalkhali-Ellis, Children’s Memorial Research Center,
Chicago, Il. Lipofectamine 2000 was from Invitrogen,
Carlsbad, CA. The EZ-ChIP kit was purchased from
Millipore Inc., Billerica, MA.
Cell culture
Normal prostate epithelial PrEC cells (Clonetics-Bio-
whittaker) were cultured in PrEMB medium. The human
prostate cancer cell lines, LNCaP, 22Rv1 and DU145,
were obtained from ATCC, Manassas, VA. The LNCaP,
C4-2 human prostate cancer progression model was
established as described previously [20], while generation
of C4-2 cells with stable Snail knockdown has been
reported previously [21]. Cells were grown in RPMI
medium supplemented with 5% fetal bovine serum and
1X penicillin-streptomycin, at 37°C with 5% CO2 in a
humidified incubator.
Western blot analysis
Confluent cells were lysed in a modified RIPA buffer
(50 mM Tris, pH 8.0, 150 mM NaCl, 0.02% NaN3, 0.1%
SDS, 1% NP-40, 0.5% sodium deoxycholate) containing
1.5X protease inhibitor cocktail, 1 mM phenylmethylsu-
fonyl fluoride, and 1 mM sodium orthovanadate. The
cell lysates were centrifuged, and supernatants collected
and quantified using a micro BCA assay. 25–30 μg of
cell lysate was resolved on a 4-12% SDS PAGE, followed
by transblotting onto nitrocellulose membrane (Schlei-
cher & Schuell, Keene, NH). The membranes were
blocked in TBS-TB (TBS with 0.05% Tween-20, 0.05%
BSA) containing 5% milk, and subsequently incubated
with diluted antibody in blocking buffer. After washing,
the membranes were incubated in peroxidase-conjugated
sheep anti-mouse, sheep anti-rabbit, or goat anti-rat IgG,
washed, and visualized using ECL reagent. The mem-
branes were stripped using stripping buffer (Pierce Bio-
technology, Inc., Rockford, IL) prior to re-probing with a
different antibody.
Transfection assay
Stable transfection of Snail cDNA was performed in
22Rv1 cells utilizing Lipofectamine 2000. The Snail
cDNA is the constitutively active construct (6SA) that
was previously utilized to induce EMT in MCF7 breast
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vector (Neo) was transfected into cells cultured in 12
well dishes at 90% confluency as per manufacturer’s
instructions. Stable clones were selected using 800 μg/
ml G418, isolated, and maintained in 400 μg/ml G418.
Snail expression was verified in the clones by Western
blot analysis.
RNA Isolation and RT-PCR
Total RNA was isolated from cells using the Qiagen
kit as per manufacturer’s instructions, and 1 μg reverse
transcribed with oligo-dT using MMLV-reverse tran-
scriptase (Invitrogen), to generate cDNA. PCR analyses
were subsequently performed with 2 μl of cDNA utiliz-
ing the primers and conditions as follows: Snail primers
were 5′-GCTCGAAAGGCCTTCAACTGCAAA-3′ and
5′-AGGCAGAGGACACAGAACCAGAAA-3′, Maspin
primers were 5′-CTGACAACAGTGTGAACGAC-3′ and
5′-CAAGCCTTGGGATCAATCATCT-3′, and GAPDH
primers were 5′-GAAGGTGAAGGTTCGGAGTC-3′ and
5′-GAAGATGGTGATGGGATTTC-3′. The PCR condi-
tions for Snail and GAPDH were 94°C, 2 min, 29 cycles of
94°C, 30 s; 55°C, 30 s; 72°C, 2 min, and 72°C, 7 min final
extension, while for maspin it was 95° 5 min, 35 cycles of
94° 1 min, 56° 30 secs, 72° 1 min, and 72° 5 min final
extension.
siRNA treatment
DU145 or 22Rv1 Snail-transfected cells at 70% con-
fluency were transfected with 200 nM control or Snail
smartpool siRNA (Dharmacon) using Dharmafect I re-
agent, as per manufacturer’s instructions, for 72 h prior
to isolation of protein for western blot analysis.
In vitro cell migration and invasion assay
We utilized Costar 24-well plates containing a polycar-
bonate filter insert with an 8-μ pore size, coated with
collagen I on the outside for migration or matrigel on
the inside for invasion assays. 50,000 cells were plated in
the upper chamber containing 0.1% fetal bovine serum
(FBS) while the lower chamber contained 10% FBS. 24 h
later, cells that had migrated to the bottom of the insert
was fixed, stained, and either counted to obtain the
relative migration or the stain solubilized with Sorenson
solution and OD measured at 490 nm to obtain relative
migration.
Maspin promoter luciferase-reporter assay
The full length maspin promoter [18] in pCR2.1TOPO
vector was double-digested with Sac I and Bgl II, ligated
into pGL3-basic vector and DNA sequences of the con-
structs confirmed by DNA sequencing (Morehouse School
of Medicine DNA Facility). 22Rv1 cells overexpressing
Snail or C4-2 cells with stable Snail knockdown wereplated at 6 x 105 cells/well in 6-well dishes in hormone-
depleted media. Cultures were transfected with 3 μg of
DNA from the full-length maspin promoter reporter plas-
mids and an internal renilla luciferase plasmid for trans-
fection efficiency, using Lipofectamine 2000. After 48 h,
the cells were harvested in reporter lysis buffer (Promega),
and supernatant(s) were used to determine luciferase ac-
tivity using the Dual-Glo Luciferase Assay System (Pro-
mega) according to the manufacturer’s instruction. The
results were expressed as the increased induction (or sup-
pression) of the reporter plasmid after normalization
against the internal control plasmid.
ChIP Assay
22RV1 cells either stably expressing Neo vector control
(Neo10 clone) or Snail cDNA (Snail30 clone) were used
for ChIP assay using the EZ-ChIP kit. The cells were
cross-linked with formaldehyde for 10 min at 37°C with
mild shaking, washed in ice cold PBS, unreacted formal-
dehyde was quenched with glycine, then washed with
PBS and resuspended in SDS buffer. Samples were soni-
cated to approximately 600 bps with Sonicator (Misonix
Sonicator S-3000), diluted in dilution buffer with inhibi-
tors and precleared with agarose G beads. The super-
natant was used directly in immunoprecipitation with
anti-Snail, IgG (for negative control) or RNA polymerase
II (for positive control). The immunocomplexes were
mixed with 120 μl of DNA coated agarose G beads fol-
lowed by incubation overnight. Pellets were washed in a
low salt wash buffer (x1), high salt wash buffer (x1), LiCl
wash buffer (x1) and TE buffer (x2). This was followed
by adding 200 μl of elution buffer to elute the protein/
DNA complex and cross-linking was reversed by adding
5 M NaCl with incubation overnight. The protein was
then digested by addition of 1 μl proteinase K to each
sample followed by incubation for 2 hrs. DNA was puri-
fied by washing with elution buffer and centrifugation
and then subsequently processed by PCR.
Quantitative Real-Time PCR (QRT-PCR)
2 μl of the DNA eluates from the ChIP assay were added
into a 96 well QPCR plate for each corresponding sam-
ple. Subsequently a master mix was made using maspin
promoter primers (catalog number GPH1006313(−)01A,
from SA Biosciences, Frederick, MD), and the RT2
qPCR mastermix reagent (catalog number PA-011, from
SA Biosciences) according to manufacterer’s instruc-
tions. QRT-PCR was then done using an I-cycler (Bio-
Rad) to quantitate transcript levels by the SYBR Green
method. Cycle threshold differences were then deter-
mined using an I-cycler (Bio-Rad) relative to input
chromatin (chromatin initially used for the immunopreci-
pation). Fold changes in transcript levels of maspin gene
were then calculated in samples immunoprecipitated with
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(negative control), or Snail antibody. The results
were graphed and the standard error determined.
Samples were also resolved on an agarose gel. As an-
other control PCR was performed with primers to mas-
pin intronic region. The primer sequence was Forward:
5′- AGGAGCCAGTCAGCATAGGA- 3′ and Reverse:
5′- TTTGGCTGCAAACACCTACA- 3′.Results
Snail overexpression negatively correlates with maspin
expression
We examined the expression of Snail transcription factor
in normal prostate epithelial cells and different prostate
cancer cell lines by RT-PCR and Western blot analysis.
The normal prostate epithelial cells (PrEC) failed to ex-
press detectable levels of Snail, while Snail was readily
detectable in the prostate cancer cell lines LNCaP, the
LNCaP derivative cell line C4-2, DU145, and not detect-
able in 22Rv1 cells (Figure 1A, B). Conversely, PReC
normal epithelial cells expressed high levels of maspin as
compared to the prostate cancer cell lines (Figure 1A,
B). This demonstrates that Snail expression is inversely
correlated with maspin expression in normal epithelial
prostate cells and prostate cancer cell lines.Figure 1 Snail expression correlates inversely with maspin
expression in normal and prostate cancer cell lines. Normal
immortalized epithelial cells (PrEC), the LNCaP prostate cancer
progression model (LNCaP, C4-2), DU145 and 22Rv1 cells were
utilized to analyze Snail and maspin levels by (A) PCR and (B)
Western blot analyses. GAPDH and actin were utilized as loading
controls for PCR and Western blot analysis, respectively. All
experiments were performed at least 3 times.Overexpression of Snail in 22Rv1 prostate cancer cells
leads to decreased expression of maspin and increased
migration/invasion
Since we had observed an inverse relation between Snail
and maspin, we sought to investigate whether Snail
could regulate maspin expression. We decided to utilize
androgen-dependent 22Rv1 cells to represent a prostate
cancer cell model that expresses undetectable levels of
Snail in order to overexpress Snail and subsequently
examine maspin expression. We utilized lipofectamine
2000 to overexpress Snail cDNA or empty vector control
(Neo) in 22Rv1 prostate cancer cells. Stable clones were
selected with G418 and tested for expression of Snail
and maspin by RT-PCR and Western blot analysis.
22Rv1 Snail clone high demonstrated the highest levels
of Snail that corresponded with the lowest levels of mas-
pin when compared to 22Rv1 Neo control or Snail low
clone that expressed low levels of Snail by RT-PCR and
Western blot (Figure 2A). 22Rv1 Snail high clone, which
displayed the highest levels of Snail, also displayed
increased migration (p = 0.06) and invasion (**p < 0.01)
as compared to 22Rv1 Neo control (Figure 2B, C). These
results suggest that Snail overexpression can result in
maspin inhibition as well as increased migration and in-
vasion in 22Rv1 prostate cancer cells.
Knockdown of Snail expression can reinduce maspin
expression
Next we examined whether inhibition of Snail in pros-
tate cancer cells could lead to maspin reexpression. We
utilized AR-negative DU145 cells and AR-positive C4-2
cells to check whether AR was required for regulation of
maspin by Snail. We also utilized these cell lines because
they represent androgen-independent, aggressive cell
lines that express higher levels of Snail. DU145 cells
transfected with Snail or control siRNA for 3 days were
examined for Snail and maspin expression as well as mi-
gratory potential on collagen using a Boyden chamber
assay. The data showed that Snail knockdown did result
in decreased Snail mRNA and protein expression,
increased maspin expression and decreased cell migra-
tion (p = 0.071) when compared to control siRNA treat-
ment (Figure 3A, B). Similarly, stable knockdown of
Snail in C4-2 cells using shRNA (C4-2 E8) resulted in
decreased expression of Snail, increased expression of
maspin, and decreased cell migration (p = 0.072) when
compared to control non silencing shRNA (C4-2 NS)
expressing cells (Figure 3C, D). Therefore, Snail knock-
down may alleviate maspin inhibition in AR-negative
and –positive prostate cancer cell lines.
Snail negatively regulates activity of maspin promoter
We sought to examine the molecular mechanisms by
which Snail may be inhibiting maspin expression. We
Figure 2 Snail overexpression in 22Rv1 cells leads to decreased maspin expression, and increased migratory and invasive potential.
22Rv1 prostate cancer cells were stably transfected with Snail cDNA or empty vector control (Neo) using lipofectamine 2000. (A) A representative
Snail clone (Snail-high) that expressed the highest levels of Snail, as assayed by PCR and Western blot analysis, also expressed the least amount of
maspin, when compared to Neo control and the low-expressing Snail clone (Snail-low). (B) Snail overexpression in 22Rv1 cells was accompanied
by increased migration on collagen and (C) increased invasion on matrigel in the Snail-high clone. Results are representative of three
independent experiments. Data represent mean± SD (* p < 0.05, **p < 0.01).
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binds to which is CAGGTG or CANNTG) within the
maspin promoter, 1000 bps upstream of the start site,
using ConSite software (Figure 4A). Therefore, we
hypothesized that Snail may regulate maspin at the pro-
moter level. We obtained full length maspin promoter
and ligated it to the luciferase vector. We utilized 22Rv1
and LNCaP cells with stable Snail overexpression or C4-
2 cells with stable endogenous Snail knockdown to
examine maspin promoter activity by transiently trans-
fecting full length maspin promoter (Maspin-Luc) plus
renalla luciferase vector as an internal control, for 48 h.
We also utilized parental LNCaP or 22Rv1 prostate can-
cer cells transiently co-transfected with Snail or Neo
cDNA and Maspin-luc for 48 h and β-galactosidase (β-
gal) as an internal control. Subsequently, luciferase activ-
ity was measured and normalized to renalla luciferase or
β-gal. Transient or stable Snail transfection led to sig-
nificantly decreased maspin promoter activity as com-
pared to Neo control in both 22Rv1 and LNCaP cells(Figure 4B, Additional file 1: Figure S1). Conversely,
stable knockdown of Snail in C4-2 cells (C4-2 E8)
increased maspin promoter activity as compared to C4-
2 NS non-silencing control (Figure 4C). These results
suggest that Snail can negatively regulate maspin
promoter activity.
Snail transcription factor binds to maspin promoter
Because we had shown that Snail can negatively regulate
maspin promoter activity, we investigated whether Snail
can physically bind to the maspin promoter. A ChIP
assay was performed using 22Rv1 Neo or Snail-
transfected cells to immunoprecipitate Snail from chro-
matin and perform real-time PCR with maspin promoter
primers that spanned the first E-box upstream of the
start site (Figure 5A). Mouse IgG was utilized as a nega-
tive control while anti-RNA Polymerase II antibody was
utilized as a positive control. ChIP-PCR was also per-
formed with maspin intron primers as another control.
The data revealed Snail binding to maspin promoter
Figure 3 Downregulation of Snail in DU145 and C4-2 cells is associated with increased maspin expression and decrease in cell
migratory potential. (A) DU145 cells were transiently transfected with control or Snail siRNA for 3 days followed by PCR and Western blot
analysis for Snail and maspin expression. (B) 5X104 DU145 cells that had been treated with control or Snail siRNA was plated in a Boyden
chamber and tested for migration on collagen. There was a decrease in migration (mean± SD, p = 0.071). (C) C4-2 cells stably transduced with
non-silencing control (NS) or Snail shRNA lentiviral vectors (E8) displayed decreased Snail and increased maspin expression by PCR and Western
blot analysis. (D) 5X104 C4-2 control- or Snail shRNA-expressing cells were tested for migration on collagen using a Boyden chamber. There was a
decrease in migration (mean± SD, p = 0.072) Results are representative of triplicate experiments performed independently.
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Neo control cells (Figure 5B, C). Therefore, Snail overex-
pression may lead to maspin repression in part through
binding of Snail to maspin promoter.Figure 4 Snail can negatively regulate maspin promoter activity. (A) A
E-boxes. 22Rv1 cell lines stably overexpressing Snail (Snail-high clone) or ve
or non-silencing control (C4-2 NS) were plated at 6 x 105 cells/well in 6-we
subsequently transfected with 3 μg of DNA from the full-length maspin pr
luciferase for transfection efficiency) using Lipofectamine 2000. After 48 h, a
showed that (B) maspin promoter activity was decreased in 22Rv1 cells ov
C4-2 cells with stable Snail knockdown. The experiments were performed i
Student’s t test compared with control.Discussion
Our research focused on studying the mechanism(s) by
which Snail transcription factor may contribute to can-
cer progression in prostate cancer. One of the ways bynalysis of maspin promoter region with ConSite software revealed 8
ctor control (Neo) or C4-2 cells with stable Snail knockdown (C4-2 E8)
ll dishes overnight in hormone-depleted media. Cells were
omoter reporter plasmid and an internal control plasmid (renilla
nalysis of luciferase activity relative to renalla luciferase activity
erexpressing Snail and (C) maspin promoter activity was increased in
n triplicate at least three times independently. Bars, SD *, P < 0.05,
Figure 5 Snail binds to the maspin promoter. 22Rv1 cell lines stably overexpressing Snail (Snail-high clone) or vector control (Neo) were
utilized to perform ChIP analysis. (A) The maspin promoter region is shown with the putative E-boxes; the ChIP Q-PCR primer recognized the first
E-box upstream of the start site. (B) Chromatin was immunoprecipitated with mouse IgG as a negative control, anti-RNA polymerase II antibody
as a positive control or anti-Snail antibody. Real-time PCR was subsequently performed with primers that recognize the maspin promoter within
the first E-box upstream of the start site. The samples were run on an agarose gel and input included as control for loading. ChIP PCR was also
performed with primers to maspin intron as another negative control. (C) The results of the real-time PCR were plotted as fold change of binding
to maspin promoter. The experiments were performed in triplicate at least three times independently. Bars, SD *, P < 0.05, Student’s t test
compared with 22Rv1 Neo control.
Neal et al. BMC Cancer 2012, 12:336 Page 7 of 9
http://www.biomedcentral.com/1471-2407/12/336which Snail can lead to cancer progression is through in-
duction of epithelial-mesenchymal transition (EMT),
which involves the loss of epithelial markers such as E-
cadherin, and acquisition of mesenchymal markers such
as vimentin [2]. Snail can negatively regulate a number
of tumor suppressors including E-cadherin, claudins,
and occludin, by binding to E-boxes in the promoter re-
gion [2,23,24]. This communication studied the relation-
ship between Snail and maspin tumor suppressor, to
discover a new mechanism by which maspin may be
downregulated during prostate tumor progression.
Maspin tumor suppressor has been shown to be down-
regulated in breast and gastric cancer through promoter
methylation [15,25,26]. Maspin expression is also lost
with prostate tumor progression, through inactivation of
a positive Ets response element and activation of a nega-
tive HRE response element recognized by AR [18]. Re-
cently, interleukin-6 (IL-6) signaling has been shown to
downregulate maspin expression [27].
The present study correlates Snail expression with
prostate cancer, as Snail protein was absent in normal
immortalized prostate epithelial cells (PrEC), however it
was then expressed in our LNCaP progression model(LNCaP, C4-2), DU145 prostate cancer cell lines, though
undetectable in 22Rv1 cells. Conversely, maspin expres-
sion was high in PrEC and low in the prostate cancer
cell lines. The inverse relationship between Snail and
maspin led us to investigate whether Snail may be nega-
tively regulating maspin expression. Indeed, we found
that when Snail is overexpressed in 22Rv1 cells, maspin
expression was decreased, while migratory and invasive
potential increased. Conversely, when Snail expression
was inhibited with siRNA or shRNA in DU145 or C4-2
cells, respectively, maspin expression increased, while
migratory potential decreased. This study reports evi-
dence for the first time, that Snail oncogene can nega-
tively regulate maspin tumor suppressor. Since maspin is
silenced epigenetically in some cancers, studies aim at
preventing tumor progression by reinducing maspin
expression with methylation inhibitors such as 5- aza-
2 ′-deoxycytidine and histone deacetylase inhibitors
[28-30]. These are general inhibitors that would lead
to non-specific demethylation. We provide a novel
mechanism by which therapeutic targeting of Snail in
the future, may prevent tumor cell migration by rein-
ducing maspin expression.
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ently or stably transfected with Snail to show that Snail
does significantly reduce maspin promoter activity, while
knockdown of endogenous Snail in C4-2 cells increased
maspin promoter activity. To elucidate the mechanism,
we have found 8 E-boxes within the maspin promoter
and showed that Snail directly binds to the maspin pro-
moter in 22Rv1 cells. Our data suggest that Snail may
repress maspin independently of AR since knockdown
of Snail resulted in decreased maspin expression in both
AR-negative DU145 and AR-positive C4-2 cells. It is also
possible that Snail may negatively regulate maspin by
recruiting histone deacteylases (HDACs). Although Snail
has been shown to directly bind to the E-cadherin pro-
moter, it can also repress E-cadherin epigenetically by
recruiting a corepressor, Ajuba LIM domain protein
resulting in histone modifications and promoter methy-
lation [31,32]. It was reported that receptor activator of
NF-kappa B ligand (RANKL) signaling to Ikappa B kin-
ase alpha (IKKalpha) represses maspin expression in
prostate epithelial cells, associated with nuclear trans-
location of IKKalpha [33]. We have previously shown
that Snail can induce the expression of RANKL [19], so
it is possible that Snail may be repressing maspin
through the RANKL-IKKalpha pathway. Alternatively,
p53 has been shown to bind to maspin promoter leading
to activation of its transcription [34,35], while Snail
interacts directly with the DNA binding domain of p53
diminishing its tumor suppressive function [36], there-
fore, it seems plausible that Snail may inhibit maspin via
p53 pathway. Thus although we report one step in
which Snail directly binds to maspin promoter to inhibit
its promoter activity and expression, this does not ex-
clude other possibilities by which Snail may negatively
regulate maspin.
Conclusions
Collectively, our results indicate for the first time that
Snail can negatively regulate maspin through direct pro-
moter repression resulting in increased migration and
invasion in prostate cancer cells. This study reveals a
novel mechanism of how Snail may function and show
the importance of therapeutic targeting of Snail signaling
in future.
Additional file
Additional file 1: Snail overexpression represses maspin promoter
activity in LNCaP and 22Rv1 cells. We transiently co-transfected LNCaP
or 22Rv1 prostate cancer cells with Snail or Neo cDNA and full length
maspin promoter (Maspin-luc) for 48 h. We also utilized LNCaP cells
stably overexpressing Snail as shown by PCR analysis (Snail-medium and
Snail-high clones) as compared to the Neo control (LNCaP Neo) as
shown in Additional file 1: Figure S1C, and used the representative Snail-
high clone to analyze maspin promoter activity. As an internal control, allcells were transfected with β-galactosidase (β-gal) for the transient
transfections and renilla luciferase for the stable transfection.
Subsequently, luciferase activity was measured and normalized to β-gal
or renilla luciferase. Snail transfection led to significantly decreased
maspin promoter activity as compared to Neo transfection in both
LNCaP and 22Rv1 cells (Additional file 1: Figure S1). These results suggest
that Snail can negatively regulate maspin promoter activity.
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